| CAS ID: | 723-46-6 |
| Molecular Formula: | C10H11N3O3S |
| Molecular Weight: | 253.3 g/mol |
| Monoisotopic Mass: | 253.0521 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | RO 4-2130 | UROBAK | SULPHAMETHOXAZOLE | SULFAMETHOXAZOLE SODIUM | Sinomin | GANTANOL | GANTANOL-DS | Acetylsulfamethoxazole | Suphamethoxazole | SULFAMETHOXAZOLE |
| Analysis: | Drug repositioning mechanism analysis |
Trial Record 1
| ClinicalTrial ID | NCT02759120 | Disease | Idiopathic pulmonary fibrosis |
| Phase | Phase 3 | Status | Recruiting |
| First Received | May 3, 2016 | Last Verified | January 21, 2019 |
| Sponsor | Weill Medical College of Cornell University | ||
Trial Record 2
| ClinicalTrial ID | NCT01349192 | Disease | Cystic fibrosis |
| Phase | Phase 2 | Status | Terminated |
| First Received | May 6, 2011 | Last Verified | May 15, 2017 |
| Sponsor | University of North Carolina, Chapel Hill | ||
Trial Record 3
| ClinicalTrial ID | NCT01594827 | Disease | Cystic fibrosis |
| Phase | Phase 2 | Status | Completed |
| First Received | May 9, 2012 | Last Verified | February 26, 2019 |
| Sponsor | Johns Hopkins University | ||
Trial Record 4
| ClinicalTrial ID | NCT00636935 | Disease | Pulmonary fibrosis |
| Phase | Phase 4 | Status | Withdrawn |
| First Received | March 17, 2008 | Last Verified | June 27, 2017 |
| Sponsor | George Washington University | ||